PT2003978E - Terapia de células alogeneicas para o tratamento de infeção oportunista - Google Patents

Terapia de células alogeneicas para o tratamento de infeção oportunista Download PDF

Info

Publication number
PT2003978E
PT2003978E PT67501965T PT06750196T PT2003978E PT 2003978 E PT2003978 E PT 2003978E PT 67501965 T PT67501965 T PT 67501965T PT 06750196 T PT06750196 T PT 06750196T PT 2003978 E PT2003978 E PT 2003978E
Authority
PT
Portugal
Prior art keywords
treatment
cell therapy
opportunistic infection
allogeneic cell
allogeneic
Prior art date
Application number
PT67501965T
Other languages
English (en)
Inventor
Michael Har-Noy
Original Assignee
Immunovative Therapies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovative Therapies Ltd filed Critical Immunovative Therapies Ltd
Publication of PT2003978E publication Critical patent/PT2003978E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4641—Fungal antigens, e.g. Trichophyton, Aspergillus or Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/26—Universal/off- the- shelf cellular immunotherapy; Allogenic cells or means to avoid rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT67501965T 2006-04-13 2006-04-13 Terapia de células alogeneicas para o tratamento de infeção oportunista PT2003978E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/014088 WO2007120128A1 (en) 2006-04-13 2006-04-13 Allogeneic cell therapy for treatment of opportunistic infection

Publications (1)

Publication Number Publication Date
PT2003978E true PT2003978E (pt) 2014-07-25

Family

ID=38609793

Family Applications (1)

Application Number Title Priority Date Filing Date
PT67501965T PT2003978E (pt) 2006-04-13 2006-04-13 Terapia de células alogeneicas para o tratamento de infeção oportunista

Country Status (11)

Country Link
EP (1) EP2003978B1 (pt)
JP (1) JP5254952B2 (pt)
CA (1) CA2649290C (pt)
CY (1) CY1115446T1 (pt)
DK (1) DK2003978T3 (pt)
ES (1) ES2482141T3 (pt)
IL (1) IL194667A (pt)
PL (1) PL2003978T3 (pt)
PT (1) PT2003978E (pt)
SI (1) SI2003978T1 (pt)
WO (1) WO2007120128A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7435592B2 (en) 2003-05-13 2008-10-14 Immunovative Therapies, Ltd. Compositions for allogeneic cell therapy
US20120128656A1 (en) * 2008-05-02 2012-05-24 Immunovative Therapies, Ltd. Vaccine compositions and methods
CN103002915B (zh) * 2010-04-13 2015-09-23 免疫创新治疗有限公司 抑制Treg细胞的方法和组合物
EP2601957B1 (en) * 2010-08-06 2019-04-10 Canine-Lab. Inc. Immunological function enhancing agent
BR112013028285A2 (pt) 2011-05-03 2017-01-10 Immunovative Therapies Ltd indução de il-12 usando imunoterapia
TWI676481B (zh) * 2012-05-02 2019-11-11 以色列商梵提夫免疫療法公司 使用免疫療法誘導ｉｌ－１２
CA2782942C (en) 2012-07-12 2019-08-27 Canadian Blood Services Method for inducing immune tolerance using polymer-modified antigenic leukocytes
DK3019176T3 (da) 2013-07-12 2020-06-22 Canadian Blood Services Anvendelse af acellulære pro-inflammatoriske sammensætninger og fremgangsmåde til fremstilling heraf
EP3166618B1 (en) 2014-07-10 2021-01-13 Canadian Blood Services Combination therapy of a cellular pro-tolerogenic and pro-inflammatory preparations for modulating the immune system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE405291T1 (de) * 1993-06-23 2008-09-15 Peter Leskovar Mittel zur beeinflussung von hyperaktivierten immunologischen effektorzellen

Also Published As

Publication number Publication date
PL2003978T3 (pl) 2014-12-31
EP2003978A1 (en) 2008-12-24
DK2003978T3 (da) 2014-07-07
JP2009533430A (ja) 2009-09-17
SI2003978T1 (sl) 2014-11-28
CA2649290C (en) 2017-04-04
WO2007120128A1 (en) 2007-10-25
EP2003978B1 (en) 2014-06-11
JP5254952B2 (ja) 2013-08-07
ES2482141T3 (es) 2014-08-01
EP2003978A4 (en) 2009-07-22
IL194667A (en) 2015-06-30
CY1115446T1 (el) 2017-01-04
CA2649290A1 (en) 2007-10-25

Similar Documents

Publication Publication Date Title
EP2003978A4 (en) ALLOGENIC CELL THERAPY TO TREAT OPPORTUNISTIC INFECTION
EP2155197A4 (en) TREATMENT OF LYSOSOMAL STORAGE DISEASES
EP2129369A4 (en) TREATMENT OF ADHD
EP2470257A4 (en) BONE IMPLANTS FOR THE TREATMENT OF INFECTIONS
ZA200906126B (en) Use of IL-23 antigonists for treatment of infection
GB0610867D0 (en) Treatment of pain
EP2273989A4 (en) POLYTHERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS
EP2155225A4 (en) METHODS OF TREATING SKIN ULCERS
IL193748A0 (en) Treatment of pain
GB0718446D0 (en) Compositions and methods for the treatment of infection
EP2054066A4 (en) METHOD FOR TREATING RADIATION ENTITY
ZA201200017B (en) Formulations for the treatment of deeep tissue pain
EP2300599A4 (en) INCREASING THE EFFECTIVENESS OF CELL THERAPY, INCLUDING TREATMENT WITH ALPHA-1-3-FUCOSYLTRANSFERASE
EP2101697A4 (en) TREATMENT OF MEIBOM DRILLS
PL2280717T3 (pl) Środek terapeutyczny dla chorób beztlenowych
EP2029156A4 (en) POLY THERAPY FOR TREATING CANCER
ZA201000225B (en) Treatment of depression
IL210066A0 (en) Novel ortho-aminoanilides for the treatment of cancer
EP2207516A4 (en) DEVICE FOR THE TREATMENT OF VAGINAL MYCOSIS
GB0708452D0 (en) Treatment of nuclear studge
GB0610868D0 (en) Treatment of pain
GB0723100D0 (en) Treatment of HFnEF
EP2403507A4 (en) TREATMENT OF INFECTIONS
GB0815179D0 (en) Medication and treatment for infection
GB0616450D0 (en) Treatment of pain